Skip to main content

Government News

Crack GPAT — Prepare for GPAT Online 
  • Now CROs require authorisation from Central Licencing Authority

    As per new amendment of New Drugs and Clinical Trials, Clinical Research Organisations cannot conduct any clinical trial or bioavailability studies without permission from Central Licencing Authority.

    As per new amendment, application for registration of Clinical Research Organisation for the purpose of conducting clinical trial or bioavailability or bioequivalence study with the Central Licencing Authority shall be made to the said authority in Form CT-07B.

  • Cabinet approves the Policy for the Medical Devices Sector

    The Union Cabinet, chaired by the Hon'ble Prime Minister Shri Narendra Modi, today approved the National Medical Devices Policy, 2023.

  • AIOCD writes DCGI on irregularities by online pharmacy continues

    The All India Organisation of Chemists & Druggists (AIOCD) has written to the Drug Controller General of India (DCGI) on operations of online Pharmacies. AIOCD stated that despite the issuance of notices, E-Pharmacy companies have not stopped their operations.

  • No Custom duty on import of medicines used in rare diseases, says India

    Government has given full exemption from custom duty on import of medicines used in rare diseases. The Central Government has given full exemption from basic customs duty on all drugs and Food for Special Medical Purposes imported for personal use for treatment of all Rare Diseases listed under the National Policy for Rare Diseases 2021 through a general exemption notification.

  • Government to set up 270 pharmacies in Eastern Railways

    Healthcare facilities such as pharmacies and collection centres for pathology laboratories will be established at 270 stations in the Eastern Railway zone by the end of this year.

    “In a bid to spread healthcare facilities to the remotest corner of its network, the Eastern Railway has awarded the contract for setting up healthcare-focused multi-utility stores at 270 stations for a period of five years,” Arora told reporters.

  • PCI invites Government faculty for panel empanelment of Exit Exam

    Pharmacy council of India is preparing for the exit exam for Diploma pharmacy. PCI invites Government faculty for panel empanelment of Exit Exam.

    PCI (Pharmacy council of India) said in a notification that this is to bring to kind information that Exit Examination for Diploma in Pharmacy has to be conducted. Faculty from Government and Government Aided colleges are hereby informed to fill the form for being considered as an expert.

  • IPC indicates ADRs associated with Cephalosporins and Amikacin

    Indian Pharmacopoeia commission, IPC indicated adverse drug interactions associated with widely used antibiotic cephalosporins and Amikacin.

    Cephalosporins are beta-lactam antimicrobials used to manage a wide range of infections from Gram-positive and Gram-negative bacteria.And Amikacin is indicated in the treatment of serious infections due to amikacin sensitive organisms.

  • PCI signs MoU with KDPMA, LSSSDC, IPA and FOPE to reduce the gap of industry and academia

    Dr. Bharati Pravin Pawar, Minister of State inaugurates Pharma Anveshan-2023 on the occasion of National Pharmacy Education Day

  • Exit exam for D.Pharm is established by PCI

    Pharmacy council of India has finalised that the exit exam of Diploma in pharmacy candidates will be implemented from 2022-2023 batch of D.Pharm course.

  • National Action Plan on containment of Antimicrobial Resistance

    National Action Plan on containment of Antimicrobial Resistance (NAP-AMR) was launched on 19th April, 2017. National AMR surveillance network of state medical college labs (NARS-Net) has been established to generate quality data on AMR for priority bacterial pathogens of public health importance.

    AMR surveillance network of state medical college labs (NARS-Net) established to generate quality data on AMR.

Subscribe to Government News